Literature DB >> 25851324

Basal hyperaemia is the primary abnormality of perfusion in Takotsubo cardiomyopathy: a quantitative cardiac perfusion positron emission tomography study.

Thomas Emil Christensen1, Kiril Aleksov Ahtarovski2, Lia Evi Bang2, Lene Holmvang2, Helle Søholm2, Adam Ali Ghotbi3, Hedvig Andersson2, Niels Vejlstrup2, Nikolaj Ihlemann2, Thomas Engstrøm2, Andreas Kjær4, Philip Hasbak5.   

Abstract

AIMS: Takotsubo cardiomyopathy (TTC) is characterized by acute completely reversible regional left ventricle (LV) akinesia and decreased tracer uptake in the akinetic region on semi-quantitative perfusion imaging. The latter may be due to normoperfusion of the akinetic mid/apical area and basal hyperperfusion. Our aim was to examine abnormalities of perfusion in TTC, and we hypothesized that basal hyperperfusion is the primary perfusion abnormality in the acute state. METHOD AND
RESULTS: Twenty-five patients were diagnosed with TTC due to (i) acute onset of symptoms, (ii) typical apical ballooning, (iii) absence of significant coronary disease, and (iv) complete remission on 4-month follow-up. The patients underwent coronary angiography (CAG), echocardiography, cardiac magnetic resonance imaging (CMR), and (13)NH3/(82)Rb positron emission tomography (PET) in the acute state and-except CAG-on follow-up. Patients initially had severe heart failure, mid/apical oedema but no infarction, and a rise in cardiac biomarkers. On initial perfusion PET imaging, eight patients appeared to have normal, whereas 17 patients had impaired LV perfusion. In the latter, flow in the basal region was increased in the acute state (1.5 ± 0.1 vs. 1.2 ± 0.1 mL/g/minRPP-corrected, P < 0.01), whereas midventricular (1.7 ± 0.1 vs. 1.6 ± 0.1 mL/g/minRPP-corrected, P = 0.21) and apical (1.4 ± 0.1 vs. 1.5 ± 0.1 mL/g/minRPP-corrected, P = 0.36) flow was unchanged between acute and follow-up, and within normal range.
CONCLUSION: Our results suggest an abnormal LV perfusion distribution in the acute state of TTC with basal hyperperfusion and a normoperfused akinetic region. The proportion of patients without visualized perfusion abnormalities in the acute state may represent a subgroup with fast remission. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Takotsubo cardiomyopathy; apical ballooning; cardiac MR; perfusion PET; reversible heart failure

Mesh:

Substances:

Year:  2015        PMID: 25851324     DOI: 10.1093/ehjci/jev065

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  9 in total

Review 1.  The role of multimodality imaging in takotsubo cardiomyopathy.

Authors:  Osamu Manabe; Masanao Naya; Noriko Oyama-Manabe; Kazuhiro Koyanagawa; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2018-06-01       Impact factor: 5.952

Review 2.  Updates on Stress Imaging Testing and Myocardial Viability With Advanced Imaging Modalities.

Authors:  Sandeep S Hedgire; Michael Osborne; Daniel J Verdini; Brian B Ghoshhajra
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-04

Review 3.  Stepwise approach for diagnosis and management of Takotsubo syndrome with cardiac imaging tools.

Authors:  Francesco Santoro; Adriana Mallardi; Alessandra Leopizzi; Enrica Vitale; Thomas Stiermaier; Paolo Trambaiolo; Matteo Di Biase; Ingo Eitel; Natale Daniele Brunetti
Journal:  Heart Fail Rev       Date:  2022-01-18       Impact factor: 4.214

4.  Mechanical interventricular dependency supports hemodynamics in tako-tsubo cardiomyopathy.

Authors:  Juan Lei; Zhongxia Sun; Lingchun Lyu; Randall G Green; Ernest Scalzetti; David Feiglin; Jingfeng Wang; Kan Liu
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

5.  Multi-modality imaging evaluation of recurrent Tako-tsubo syndrome in a patient with coronary artery fibromuscular dysplasia.

Authors:  Yun Cheng; Chenying Lu; Kan Liu
Journal:  Cardiovasc Ultrasound       Date:  2017-11-30       Impact factor: 2.062

6.  International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management.

Authors:  Jelena-Rima Ghadri; Ilan Shor Wittstein; Abhiram Prasad; Scott Sharkey; Keigo Dote; Yoshihiro John Akashi; Victoria Lucia Cammann; Filippo Crea; Leonarda Galiuto; Walter Desmet; Tetsuro Yoshida; Roberto Manfredini; Ingo Eitel; Masami Kosuge; Holger M Nef; Abhishek Deshmukh; Amir Lerman; Eduardo Bossone; Rodolfo Citro; Takashi Ueyama; Domenico Corrado; Satoshi Kurisu; Frank Ruschitzka; David Winchester; Alexander R Lyon; Elmir Omerovic; Jeroen J Bax; Patrick Meimoun; Guiseppe Tarantini; Charanjit Rihal; Shams Y-Hassan; Federico Migliore; John D Horowitz; Hiroaki Shimokawa; Thomas Felix Lüscher; Christian Templin
Journal:  Eur Heart J       Date:  2018-06-07       Impact factor: 29.983

Review 7.  Coronary blood flow in heart failure: cause, consequence and bystander.

Authors:  Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2022-01-13       Impact factor: 12.416

8.  Serial changes of myocardial perfusion imaging in takotsubo and reverse takotsubo cardiomyopathy.

Authors:  Keisuke Miyajima; Kei Tawarahara; Norihito Saito
Journal:  J Nucl Cardiol       Date:  2021-08-24       Impact factor: 3.872

9.  Takotsubo Syndrome: Clinical Manifestations, Etiology and Pathogenesis.

Authors:  Ekaterina S Prokudina; Boris K Kurbatov; Konstantin V Zavadovsky; Alexander V Vrublevsky; Natalia V Naryzhnaya; Yuri B Lishmanov; Leonid N Maslov; Peter R Oeltgen
Journal:  Curr Cardiol Rev       Date:  2021
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.